Minhai COVID-19 vaccine
Vaccine against COVID-19 / From Wikipedia, the free encyclopedia
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai Biological Products Co. Ltd and its subsidiary, Beijing Minhai Biotechnology Co., Ltd.
Quick Facts Vaccine description, Target ...
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Inactivated |
Clinical data | |
Other names | KCONVAC (Chinese: 可维克; pinyin: Kěwéikè) |
Routes of administration | Intramuscular |
Legal status | |
Legal status |
Close